148 related articles for article (PubMed ID: 8289586)
1. Blood luteinizing hormone and prolactin concentrations in response to naltrexone challenge: studies on rats with diabetes induced by different doses of streptozotocin.
Yogev L; Yavetz H; Gottreich A; Oppenheim D; Homonnai ZT; Paz G
Life Sci; 1994; 54(4):261-6. PubMed ID: 8289586
[TBL] [Abstract][Full Text] [Related]
2. Serum prolactin response to ether stress in diabetic rats: opiate system contribution.
Yogev L; Yavetz H; Gottreich A; Oppenheim D; Homonnai ZT; Paz G
Proc Soc Exp Biol Med; 1994 Mar; 205(3):248-52. PubMed ID: 8171046
[TBL] [Abstract][Full Text] [Related]
3. Opiate system involvement in the control of LH secretion in diabetic and normoglycemic male rats.
Yogev L; Gottreich A; Brezner E; Paz GF; Homonnai ZT
Life Sci; 1987 Aug; 41(5):585-90. PubMed ID: 3600195
[TBL] [Abstract][Full Text] [Related]
4. Changes in LH and prolactin levels in diabetic male rats and the role of the opiate system in the control of their secretion.
Yogev L; Gottriech A; Timan B; Homonnai ZT; Paz GF
Life Sci; 1985 Sep; 37(11):993-9. PubMed ID: 4033351
[TBL] [Abstract][Full Text] [Related]
5. Possible dopaminergic system involvement in LH and PRL responses to naltrexone treatment.
Yogev L; Gottreich A; Homonnai ZT; Paz GF
Life Sci; 1989; 45(24):2343-9. PubMed ID: 2601582
[TBL] [Abstract][Full Text] [Related]
6. Effects of streptozotocin-induced diabetes on neuroendocrine responses to ovariectomy and estrogen replacement in female rats.
Steger RW; Kienast SG; Pillai S; Rabe M
Neuroendocrinology; 1993 Mar; 57(3):525-31. PubMed ID: 8321421
[TBL] [Abstract][Full Text] [Related]
7. Opioid components of the clockwork that governs luteinizing hormone and prolactin release in male rats.
Almeida OF; Nikolarakis KE; Webley GE; Herz A
FASEB J; 1988 Oct; 2(13):2874-7. PubMed ID: 2844617
[TBL] [Abstract][Full Text] [Related]
8. Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat.
Briski KP; Vogel KL
Neuropeptides; 1995 Mar; 28(3):175-81. PubMed ID: 7791961
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone-induced LH release in ovariectomized estrogen-primed rats.
Higuchi T; Kawakami M
Endocrinol Jpn; 1981 Feb; 28(1):45-50. PubMed ID: 7250068
[TBL] [Abstract][Full Text] [Related]
10. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
Gilbeau PM; Almirez RG; Holaday JW; Smith CG
J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
[TBL] [Abstract][Full Text] [Related]
11. Luteinizing hormone secretion as a response to a second naltrexone administration.
Yogev L; Gottreich A; Homonnai ZT; Yavetz H; Paz GF
Proc Soc Exp Biol Med; 1990 Oct; 195(1):22-5. PubMed ID: 2399258
[TBL] [Abstract][Full Text] [Related]
12. Differential impact of naltrexone on luteinizing hormone release during single versus repetitive exposure to restraint stress.
Briski KP; Sylvester PW
Psychoneuroendocrinology; 1992; 17(2-3):125-33. PubMed ID: 1332097
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists.
Baumann MH; Rabii J
Brain Res; 1991 Dec; 567(2):224-30. PubMed ID: 1667901
[TBL] [Abstract][Full Text] [Related]
14. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
15. Effects of melatonin in vivo upon luteinizing hormone and prolactin releases induced by opiate receptor antagonists in adult male rats.
Shacoori V; Saïag B; Lemay V; Girre A; Rault B
J Endocrinol Invest; 1996 Feb; 19(2):76-82. PubMed ID: 8778169
[TBL] [Abstract][Full Text] [Related]
16. Evidence for endogenous opioid modulation of serum luteinizing hormone and prolactin in the steer.
Peck DD; Thompson FN; Stuedemann JA; Leshin LS; Kiser TE
J Anim Sci; 1988 Dec; 66(12):3197-201. PubMed ID: 3230079
[TBL] [Abstract][Full Text] [Related]
17. The paradoxical stimulatory effect of morphine on LH secretion is dose-dependent and naloxone-reversible.
Van Vugt DA; Baby N; Stewart M; Reid RL
Neuroendocrinology; 1989 Jul; 50(1):109-16. PubMed ID: 2755561
[TBL] [Abstract][Full Text] [Related]
18. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
[TBL] [Abstract][Full Text] [Related]
19. Effect of naltrexone on stress-induced bioactive prolactin release in aging male rats.
Briski KP; Sylvester PW
Neurobiol Aging; 1991; 12(2):145-9. PubMed ID: 1646967
[TBL] [Abstract][Full Text] [Related]
20. Primary hypoandrogenism in experimental diabetes in the Long-Evans rat.
Anderson JE; Jones D; Penner SB; Thliveris JA
Diabetes; 1987 Oct; 36(10):1104-10. PubMed ID: 3115851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
